Literature DB >> 24572979

Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome.

Anke L L Lameris, Christel L M Geesing, Joost G J Hoenderop, Michiel F Schreuder.   

Abstract

BACKGROUND: Williams-Beuren syndrome (WBS) is a rare genetic disorder caused by the deletion of 26-28 genes on chromosome 7. Fifteen percent of WBS patients present with hypercalcaemia during infancy, which is generally mild and resolves spontaneously before the age of 4 years. The mechanisms underlying the transient hypercalcaemia in WBS are poorly understood. CASE: We report a case of severe symptomatic hypercalcaemia in a patient with WBS, in which treatment with mild calcium restriction, hyperhydration and repeated bisphosphonate administration only resulted in short-lasting effects. Long-term lowering of serum calcium was only achieved after reducing calcium and vitamin D intake to the bare minimum.
CONCLUSIONS: This case illustrates the potential severity of hypercalcaemia in WBS, and demonstrates that both the cause as well as the solution of this problem may be found in the intestinal absorption of calcium. We hypothesise that the phenotypical resemblance between WBS and transient idiopathic infantile hypercalcaemia can be explained by similarities in the underlying genetic defect. Patients suffering from transient infantile hypercalcaemia were recently described to have mutations in CYP24A1, the key enzyme in 1,25-dihydroxyvitamin D3 degradation. In the light of this new development we discuss the role of one of the deleted genes in WBS, Williams syndrome transcription factor (WSTF), in the etiology of hypercalcaemia in WBS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24572979     DOI: 10.1515/jpem-2013-0229

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

1.  Hypercalcemia in Patients with Williams-Beuren Syndrome.

Authors:  Sampat Sindhar; Michael Lugo; Mark D Levin; Joshua R Danback; Benjamin D Brink; Eric Yu; Dennis J Dietzen; Amy L Clark; Carolyn A Purgert; Jessica L Waxler; Robert W Elder; Barbara R Pober; Beth A Kozel
Journal:  J Pediatr       Date:  2016-08-26       Impact factor: 4.406

Review 2.  Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland-Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies-2018 Update.

Authors:  Agnieszka Rusińska; Paweł Płudowski; Mieczysław Walczak; Maria K Borszewska-Kornacka; Artur Bossowski; Danuta Chlebna-Sokół; Justyna Czech-Kowalska; Anna Dobrzańska; Edward Franek; Ewa Helwich; Teresa Jackowska; Maria A Kalina; Jerzy Konstantynowicz; Janusz Książyk; Andrzej Lewiński; Jacek Łukaszkiewicz; Ewa Marcinowska-Suchowierska; Artur Mazur; Izabela Michałus; Jarosław Peregud-Pogorzelski; Hanna Romanowska; Marek Ruchała; Piotr Socha; Mieczysław Szalecki; Mirosław Wielgoś; Danuta Zwolińska; Arkadiusz Zygmunt
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-31       Impact factor: 5.555

3.  Pamidronate Rescue Therapy for Hypercalcemia in a Child With Williams Syndrome.

Authors:  Sami A Sanjad; Bilal Aoun; Halim Yammine; Amina Bassyouni; Pascale E Karam
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-14       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.